Lin; Edward Yin Shiang
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lin; Edward Yin Shiang.The latest application filed is for "azetidinyl o-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors".
Company Profile
15.28.42
- Lin; Edward Yin Shiang - Ashland MA
- LIN; Edward Yin-Shiang - Chestnut Hill MA
- Lin; Edward Yin Shiang - Cambridge MA
- Lin; Edward Yin-Shiang - Chesnut Hill MA US
Patent Activity
| Patent | Date |
|---|---|
| Azetidinyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase Inhibitors App 20220259197 - Genung; Nathan ; et al. | 2022-08-18 |
| Bicyclic Ether O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase Inhibitors App 20220106305 - Genung; Nathan ; et al. | 2022-04-07 |
| Nrf2 Activator App 20220048884 - Capacci; Andrew George ; et al. | 2022-02-17 |
| O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase Inhibitors App 20220041586 - Genung; Nathan ; et al. | 2022-02-10 |
| Morpholinyl, Piperazinyl, Oxazepanyl And Diazepanyl O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase Inhibitors App 20220017506 - Genung; Nathan ; et al. | 2022-01-20 |
| Nrf2 Activator App 20210387960 - Capacci; Andrew George ; et al. | 2021-12-16 |
| Nrf2 Activator App 20210340107 - Lucas; Brian Stuart ; et al. | 2021-11-04 |
| NRF2 activator Grant 10,968,181 - Lucas , et al. April 6, 2 | 2021-04-06 |
| Heterocyclic Compounds Useful As Pdk1 Inhibitors App 20210070752 - ARNDT; Joseph ; et al. | 2021-03-11 |
| O-glycoprotein-2-acetamido-2-deoxy-3-d-glycopyranosidase Inhibitors App 20210040080 - Genung; Nathan ; et al. | 2021-02-11 |
| S1P modulating agents Grant 10,894,040 - Thomas , et al. January 19, 2 | 2021-01-19 |
| Tetrahydronaphthalene Derivatives Useful As Nrf2 Activators App 20200299230 - Capacci; Andrew George ; et al. | 2020-09-24 |
| S1p Modulating Agents App 20200038385 - Thomas; Jermaine ; et al. | 2020-02-06 |
| Nrf2 Activator App 20190389830 - Capacci; Andrew George ; et al. | 2019-12-26 |
| Nrf2 Activator App 20190389836 - Capacci; Andrew George ; et al. | 2019-12-26 |
| Nrf2 Activator App 20190345112 - Lucas; Brian ; et al. | 2019-11-14 |
| SIP modulating agents Grant 10,406,144 - Thomas , et al. Sept | 2019-09-10 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20190209592 - Thomas; Jermaine ; et al. | 2019-07-11 |
| Heterocyclic Compounds Useful As Pdk1 Inhibitors App 20190119268 - ARNDT; Joseph ; et al. | 2019-04-25 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 10,166,250 - Thomas , et al. J | 2019-01-01 |
| Methods Of Treatment Using Pyridinonyl Pdk1 Inhibitors App 20180370966 - LIND; Kenneth Egnard ; et al. | 2018-12-27 |
| S1p Modulating Agents App 20180369215 - Thomas; Jermaine ; et al. | 2018-12-27 |
| Heterobicyclic sphingosine 1-phosphate analogs Grant 10,081,646 - Caldwell , et al. September 25, 2 | 2018-09-25 |
| S1P modulating agents Grant 10,034,869 - Thomas , et al. July 31, 2 | 2018-07-31 |
| Heterocyclic compounds useful as PDK1 inhibitors Grant 10,030,016 - Arndt , et al. July 24, 2 | 2018-07-24 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20180133233 - Thomas; Jermaine ; et al. | 2018-05-17 |
| S1p Modulating Agents App 20180028511 - Thomas; Jermaine ; et al. | 2018-02-01 |
| Methods of treatment using pyridinonyl PDK1 inhibitors Grant 9,873,693 - Lind , et al. January 23, 2 | 2018-01-23 |
| Heterobicyclic Sphingosine 1-phosphate Analogs App 20180002356 - Caldwell; Richard D. ; et al. | 2018-01-04 |
| S1P and/or ATX modulating agents Grant 9,850,206 - Peng , et al. December 26, 2 | 2017-12-26 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 9,827,258 - Thomas , et al. November 28, 2 | 2017-11-28 |
| S1P modulating agents Grant 9,808,449 - Thomas , et al. November 7, 2 | 2017-11-07 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20170239280 - Thomas; Jermaine ; et al. | 2017-08-24 |
| Heterobicyclic sphingosine 1-phosphate analogs Grant 9,708,353 - Caldwell , et al. July 18, 2 | 2017-07-18 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 9,572,824 - Thomas , et al. February 21, 2 | 2017-02-21 |
| Heterocyclic compounds useful as PDK1 inhibitors Grant 9,546,165 - Arndt , et al. January 17, 2 | 2017-01-17 |
| Heterocyclic Compounds Useful As Pdk1 Inhibitors App 20160331756 - Arndt; Joseph ; et al. | 2016-11-17 |
| S1P modulating agents Grant 9,340,527 - Thomas , et al. May 17, 2 | 2016-05-17 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20160129023 - Thomas; Jermaine ; et al. | 2016-05-12 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 9,186,367 - Thomas , et al. November 17, 2 | 2015-11-17 |
| Heterobicyclic sphingosine 1-phosphate analogs Grant 9,181,191 - Caldwell , et al. November 10, 2 | 2015-11-10 |
| S1p And/or Atx Modulating Agents App 20150274663 - Peng; Hairuo ; et al. | 2015-10-01 |
| Heterobicyclic Sphingosine 1-phosphate Analogs App 20150232492 - Caldwell; Richard D. ; et al. | 2015-08-20 |
| Pyridinonyl Pdk1 Inhibitors App 20150018351 - Lind; Kenneth Egnard ; et al. | 2015-01-15 |
| S1P Modulating Agents App 20140371209 - Thomas; Jermaine ; et al. | 2014-12-18 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20140309190 - Thomas; Jermaine ; et al. | 2014-10-16 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 8,802,659 - Thomas , et al. August 12, 2 | 2014-08-12 |
| Pyridinonyl PDK1 inhibitors Grant 8,778,977 - Lind , et al. July 15, 2 | 2014-07-15 |
| Heterobicyclic sphingosine 1-phosphate analogs App 20140100195 - Caldwell; Richard D. ; et al. | 2014-04-10 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 8,546,359 - Caldwell , et al. October 1, 2 | 2013-10-01 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20130059821 - Caldwell; Richard D. ; et al. | 2013-03-07 |
| Heterobicyclic sphingosine 1-phosphate analogs Grant 8,349,849 - Caldwell , et al. January 8, 2 | 2013-01-08 |
| Indazole derivatives as modulators of interleukin-1 receptor-associated kinase Grant 8,293,923 - Guckian , et al. October 23, 2 | 2012-10-23 |
| Bicyclic aryl sphingosine 1-phosphate analogs Grant 8,269,043 - Caldwell , et al. September 18, 2 | 2012-09-18 |
| Heterocyclic Compounds Useful As Pdk1 Inhibitors App 20120208819 - Arndt; Joseph ; et al. | 2012-08-16 |
| Bicyclic Aryl Sphingosine 1-phosphate Analogs App 20120190649 - Thomas; Jermaine ; et al. | 2012-07-26 |
| Indazole derivatives as modulators of interleukin-1 receptor-associated kinase App 20110152260 - Guckian; Kevin ; et al. | 2011-06-23 |
| Bicyclic Sphingosine 1-phosphate Analogs App 20100240617 - Lynch; Kevin R. ; et al. | 2010-09-23 |
| Heterobicyclic sphingosine 1-phosphate analogs App 20100160357 - Caldwell; Richard D. ; et al. | 2010-06-24 |
| Bicyclic aryl sphingosine 1-phosphate analogs App 20100160258 - Caldwell; Richard D. ; et al. | 2010-06-24 |
| Pyridinonyl Pdk1 Inhibitors App 20100144730 - Lind; Kenneth Egnard ; et al. | 2010-06-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 